missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18247754

Panendothelial Cell Antigen Antibody (MECA-32), Allophycocyanin/Cy7, Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals NB100-77668APCCY7

Product Code. 18247754

  • £355.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Panendothelial Cell Antigen Monoclonal specifically detects Panendothelial Cell Antigen in Human, Mouse samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Panendothelial Cell Antigen
Monoclonal
APC-Cyanine7
PBS with 0.05% Sodium Azide
Plvap
Mouse lymph node stromal cells.
0.1 mL
Primary
Pan endothelial cells except for CNS & muscle capillaries.
Store at 4°C in the dark. Do not freeze.
Flow Cytometry
MECA-32
Flow Cytometry
FELS, Fenestrated endothelial-linked structure protein, gp68, MECA32, MECA-32, Panendothelial Cell Antigen, plasmalemma vesicle associated protein, Plasmalemma Vesicle Protein 1, PV-1 protein
Rat
Protein G purified
Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Extracellular Matrix, Hypoxia, Immunology, Mesenchymal Stem Cell Markers, Stem Cell Markers
84094.0
Human, Mouse
IgG2a κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.